User:Mr. Ibrahem/Benzatropine

Benzatropine, sold under the brand name Cogentin among others, is a medication used to treat a movement disorder known as dystonia which results from antipsychotics and parkinsonism. It is not useful for tardive dyskinesia. It is taken by mouth or by injection into a vein or muscle. Benefits are seen within two hours and last for up to ten hours.

Common side effects include dry mouth, blurry vision, nausea, and constipation. Serious side effect may include urinary retention, hallucinations, hyperthermia, and poor coordination. It is unclear if use during pregnancy or breastfeeding is safe. Benzatropine is an anticholinergic which works by blocking the activity of the muscarinic acetylcholine receptor.

Benzatropine was approved for medical use in the United States in 1954. It is available as a generic medication. In the United States the wholesale cost is about US$6 per month. In 2017, it was the 226th most commonly prescribed medication in the United States, with more than two million prescriptions.